Abadie, J., Hédan, B., Cadieu, E., De Brito, C., Devauchelle, P., Bourgain, C., Parker, H. G., Vaysse, A., Margaritte-Jeannin. P., Galibert, F., Ostrander, E. A., André, C., 2009. Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese mountain dog breed. J Hered. 100 Suppl 1:S19-27.
Abodief, W. T., Dey, P., Al-Hattab, O., 2006. Cell cannibalism in ductal carcinoma of breast. Cytopathology. 17(5), 304-305.
Affolter, V. K., Moore, P. F., 2002. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol. 39, 74-83.
Amézaga, N., Sanjurjo, L., Julve, J., Aran, G., Pérez-Cabezas, B., Bastos-Amador, P., Armengol, C., Vilella, R., Escolà-Gil, J. C., Blanco-Vaca, F., Borràs, F. E., Valledor, A. F., Sarrias, M. R., 2014. Human scavenger protein AIM increases foam cell formation and CD36-mediated oxLDL uptake. J Leukoc Biol. 95(3), 509-520.
Arai, S., Kitada, K., Yamazaki, T., Takai, R., Zhang, X., Tsugawa, Y., Sugisawa. R., Matsumoto, A., Mori, M., Yoshihara, Y., Doi, K., Maehara, N., Kusunoki, S., Takahata, A., Noiri, E., Suzuki, Y., Yahagi, N., Nishiyama, A., Gunaratnam, L., Takano, T., Miyazaki, T., 2016.
Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice. Nat Med. 22, 183-193.
Arai, S., Shelton, J. M., Chen, M., Bradley, M. N., Castrillo, A., Bookout, A. L., Mak, P.A., Edwards, P. A., Mangelsdorf, D. J., Tontonoz, P., Miyazaki, T., 2005. A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. Cell Metab. 1(3), 201-213.
Aran, G., Sanjurjo, L., Bárcena, C., Simon-Coma, M., Téllez, É., Vázquez-Vitali, M., Garrido, M., Guerra, L., Díaz, E., Ojanguren, I., Elortza, F., Planas, R., Sala, M., Armengol, C., Sarrias, M. R., 2018. CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78). FASEB J. 32(7),3878-3891.
Asada, H., Tsuboi, M., Chambers, J. K., Uchida, K., Tomiyasu, H., Goto-Koshino, Y., Ohno, K., Tsujimoto, H., 2017. A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma. J Vet Med Sci. 79(10), 1721-1726.
Azakami, D., Bonkobara, M., Washizu, T., Iida, A., Kondo, M., Kato, R., Niikura, Y., Iwaki, S., Tamahara, S., Matsuki, N., Ono, K., 2006. Establishment and biological characterization of canine histiocytic sarcoma cell lines. J Vet Med Sci. 68, 1343-1346.
Bárcena, C., Aran, G., Perea, L., Sanjurjo, L., Téllez, É., Oncins, A., Masnou, H., Serra, I., García-Gallo, M., Kremer, L., Sala, M., Armengol, C., Sancho-Bru, P., Sarrias, M. R., 2019. CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content. EBioMedicine. 43, 513-524.
Bozko, M., Bozko, A., Scholta, T., Malek, N. P., Bozko, P., 2017. Editorial: DNA Damage as a Strategy for Anticancer Chemotherapy. Curr Med Chem. 24(15), 1487.
Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., Kaelin, W. G. Jr., 2004. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18(23), 2893-2904.
Canal, M., Romaní-Aumedes, J., Martín-Flores, N., Pérez-Fernández, V., Malagelada, C., 2014. RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders. Front Cell Neurosci. 8, 313.
Chen, D. S., Mellman, I., 2013. Oncology meets immunology: the cancer-immunity cycle. Immunity. 39(1), 1-10.
Chen, P., Cescon, M., Bonaldo, P., 2014. Autophagy-mediated regulation of macrophages and its applications for cancer. Autophagy. 10(2), 192-200.
Chen, R., Wang, B., Chen, L., Cai, D., Li, B., Chen, C., Huang, E., Liu, C., Lin, Z., Xie, W. B., Wang, H., 2016. DNA damage-inducible transcript 4 (DDIT4) mediates methamphetamine-induced autophagy and apoptosis through mTOR signaling pathway in cardiomyocytes. Toxicol Appl Pharmacol. 295, 1-11.
Cheng, S., Al-Agha, R., Araujo, P. B., Serri, O., L Asa, S., Ezzat, S., 2013. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly. PLoS One. 8(9), e73543.
Choi, Y., Chan, A. P., 2015. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 31(16), 2745-2747.
Choromańska, B., Myśliwiec, P., Choromańska, K., Dadan, J., Chabowski, A., 2017. The role of CD36 receptor in the pathogenesis of atherosclerosis. Adv Clin Exp Med. 26(4), 717-722.
Chu, C. P., Hokamp, J. A., Cianciolo, R. E., Dabney, A. R., Brinkmeyer-Langford, C., Lees, G. E., Nabity, M. B., 2017. RNA-seq of serial kidney biopsies obtained during progression of chronic kidney disease from dogs with X-linked hereditary nephropathy. Sci Rep. 7(1), 16776.
Craig, L. E., Julian, M. E., Ferracone, J. D., 2002. The diagnosis and prognosis of synovial tumors in dogs: 35 cases. Vet Pathol. 39(1), 66-73.
Davis, F. P., Kanno, Y., O’Shea J. J., 2015. A Metabolic Switch for Th17 Pathogenicity. Cell. 163, 1413-1427.
Dervisis, N. G., Kiupel, M., Qin, Q., Cesario, L., 2016. Clinical prognostic factors in canine histiocytic sarcoma. Vet Comp Oncol. 15(4), 1171-1180.
Du, F., Sun, L., Chu, Y., Li, T., Lei, C., Wang, X., Jiang, M., Min, Y., Lu, Y., Zhao, X., Nie, Y., Fan,
D., 2018. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways. Cancer Commun (Lond). 38(1), 45.
Durgan, J., Florey, O., 2018. Cancer cell cannibalism: Multiple triggers emerge for entosis. Biochim Biophys Acta Mol Cell Res. 1865(6), 831-841.
Elliott, J., 2018. Lomustine chemotherapy for the treatment of presumptive haemophagocytic histiocytic sarcoma in Flat-coated Retrievers. Aust Vet J. 96(12), 502-507.
Evan, G. I., Vousden, K. H., 2001. Proliferation, cell cycle and apoptosis in cancer. Nature. 411(6835), 342-348.
Fanni, D., Gerosa, C., Nemolato, S., Locci, A., Marinelli, V., Cabras, T., Messana, I., Fanos, V., Castagnola, M., Faa, G., 2011. Thymosin beta 10 expression in developing human salivary glands. Early Hum Dev. 87(12), 779-783.
Fidel, J., Schiller, I., Hauser, B., Jausi, Y., Rohrer-Bley, C., Roos, M., Kaser-Hotz, B., 2006. Histiocytic sarcomas in flat-coated retrievers: a summary of 37 cases (November 1998-March 2005). Vet Comp Oncol. 4, 63-74.
Flanagan, S. E., Patch, A. M., Ellard, S., 2010. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers. 14(4), 533-537.
Gao, X., Yan, X., Yin, Y., Lin, X., Zhang, Q., Xia, Y., Cao, J., 2019. Therapeutic Targeting of Apoptosis Inhibitor of Macrophage/CD5L in Sepsis. Am J Respir Cell Mol Biol. 60(3), 323-334.
Gerosa, C., Fanni, D., Nemolato, S., Locci, A., Marinelli, V., Cabras, T., Messana, I., Castagnola, M., Monga, G., Fanos, V., Faa, G., 2010. Thymosin beta-10 expression in developing human kidney. J Matern Fetal Neonatal Med. 23 Suppl 3, 125-128.
Gounder, M. M., Solit, D. B., Tap, W. D., 2018. Trametinib in Histiocytic Sarcoma with an Activating MAP2K1 (MEK1) Mutation. N Engl J Med. 378(20), 1945-1947.
Haruta, I., Kato, Y., Hashimoto, E., Minjares, C., Kennedy, S., Uto, H., Yamauchi, K., Kobayashi, M., Yusa, S., Müller, U., Hayashi, N., Miyazaki, T., 2001. Association of AIM, a novel apoptosis inhibitory factor, with hepatitis via supporting macrophage survival and enhancing phagocytotic function of macrophages. J Biol Chem. 276(25), 22910-22914.
Heckmann, B. L., Boada-Romero, E., Cunha, L. D., Magne, J., Green, D. R., 2017. LC3-Associated Phagocytosis and Inflammation. J Mol Biol. 429(23), 3561-3576.
Hedan, B., Thomas. R., Motsinger-Reif, A., Abadie, J., Andre, C., Cullen, J., Breen ,M., 2011. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. BMC Cancer.11, 201.
Herder, V., Iskandar, C. D., Kegler, K., Hansmann, F., Elmarabet, S. A., Khan, M. A., Kalkuhl, A., Deschl, U., Baumgärtner, W., Ulrich, R., Beineke. A., 2015. Dynamic Changes of Microglia/Macrophage M1 and M2 Polarization in Theiler’s Murine Encephalomyelitis. Brain Pathol. 25, 712-723.
Hoeffel, G., Wang, Y., Greter, M., See, P., Teo, P., Malleret, B., Leboeuf, M., Low, D., Oller, G., Almeida, F., Choy, S. H., Grisotto, M., Renia, L., Conway, S. J., Stanley, E. R., Chan, J. K., Ng, L. G., Samokhvalov, I. M., Merad, M., Ginhoux, F., 2012. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J Exp Med. 209(6), 1167-1181.
Hong, Y., Maeda, Y., Watanabe, R., Inoue, N., Ohishi, K., Kinoshita, T., 2000. Requirement of PIG-F and PIG-O for transferring phosphoethanolamine to the third mannose in glycosylphosphatidylinositol. J Biol Chem. 275(27), 20911-20919.
Huang, L., Wu, C., Yu, D., Wang ,C., Che, X., Miao, X., Zhai, K., Chang, J., Jiang, G., Yang, X., Cao, G., Hu, Z., Zhou, Y., Zuo, C., Wang, C., Zhang, X., Zhou, Y., Yu, X., Dai, W., Li, Z., Shen, H., Liu, L., Chen, Y., Zhang, S., Wang, X., Liu, Y., Sun, M., Cao, W., Gao, J., Ma, Y., Zheng, X., Cheung, S. T., Jia, Y., Tan, W., Wu, T., Lin, D., 2013. Identification of common variants in BRCA2 and MAP2K4 for susceptibility to sporadic pancreatic cancer. Carcinogenesis. 34(5), 1001-1005.
Janeway, C. A., Travers, P., Walport, M., Shlomchik, M., 2001. Imunobiology. The immune system in health and desease. 5th edition. Garland Publishing Inc.,Part 1. 1-13. Interaction with other cells as well as with antigen is necessary for lymphocyte activation.
Joseph, S. B., Bradley, M. N., Vastrilo, A., Bruhn, W., Mak, P. A., Pei, L., Hogensech, J., O’Connell, R. M., Cheng, G., Saez, E., Miller, J. F., Tontonz, P., 2004. LXR-dependent gene expression is important for macrophage survival and the innate immune re- sponse. Cell. 119(2), 299-309.
Kircher, M., Witten, D. M., Jain, P., O'Roak, B. J., Cooper, G. M., Shendure, J., 2014. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 46(3), 310-315.
Klahn, S. L., Kitchell, B. E., Dervisis, N. G., 2011. Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma. J Am Vet Med Assoc. 239(1), 90-96.
Komatsu, G., Nonomura, T., Sasaki, M., Ishida, Y., Arai, S., Miyazaki, T., 2019. AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease. Exp Anim. 68(2), 147-158.
Kurokawa, J., Arai, S., Nakashima, K., Nagano, H., Nishijima, A., Miyata, K., Ose, R., Mori, M., Kubota, N., Kadowaki, T., Oike, Y., Koga, H., Febbraio, M., Iwanaga, T., Miyazaki, T., 2010. Macrophage-derived AIM is endocytosed into adipocytes and decreases lipid droplets via
inhibition of fatty acid synthase activity. Cell Metab. 11, 479-492.
Kurokawa, J., Nagano, H., Ohara, O., Kubota, N., Kadowaki, T., Arai, S., Miyazaki, T., 2011. Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitement of inflamematory macrophages into adipose tissues. Proc Natl Acad Sci USA. 108(29), 12072-12077.
Kuwata, K., Watanabe, H., Jiang, S. Y., Yamamoto, T., Tomiyama-Miyaji, C., Abo, T., Miyazaki, T., Naito, M., 2003. AIM inhibits apoptosis of T cells and NKT cells in Corynebacterium-induced granuloma formation in mice. Am J Pathol. 162, 837-847.
Lenz, J. A., Furrow, E., Craig, L. E., Cannon, C. M., 2017. Histiocytic sarcoma in 14 miniature schnauzers - a new breed predisposition? J Small Anim Pract. 58(8), 461-467.
Li, W. H., Zhang, H., Guo, Q., Wu, X. D., Xu, Z. S., Dang, C. X., Xia, P., Song, Y. C., 2015. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. Dis Markers. 2015, 657570.
Li, W., Baker, N. E., 2007. Engulfment is required for cell competition. Cell. 129, 1215-1225.
Li, Y., Bai, M., Xu, Y., Zhao, W., Liu, N., Yu, J., 2018. TPPP3 Promotes Cell Proliferation, Invasion and Tumor Metastasis via STAT3/ Twist1 Pathway in Non-Small-Cell Lung Carcinoma. Cell Physiol Biochem. 50(5), 2004-2016.
Li, Y., Qu, P., Wu, L., Li, B., Du, H., Yan, C., 2011. Api6/AIM/Spα/CD5L overexpression in alveolar type II epithelial cells induces spontaneous lung adenocarcinoma. Cancer Res. 71(16), 5488-5499.
Lieberman, J., 2003. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol. 3(5), 361-370.
Logan, T., Bendor, J., Toupin, C., Thorn, K., Edwards, R. H., 2017. α-Synuclein promotes dilation of the exocytotic fusion pore. Nat Neurosci. 20(5), 681-689.
Lugini, L., Matarrese, P., Tinari, A., Lozupone, F., Federici, C., Iessi, E., Gentile, M., Luciani, F., Parmiani, G., Rivoltini, L., Malorni, W., Fais, S., 2006. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res. 66(7), 3629-3638.
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., Groom, A. C., 1998. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol. 153, 865-873.
Maeda, S., Tomiyasu, H., Tsuboi, M., Inoue, A., Ishihara, G., Uchikai, T., Chambers, J. K., Uchida, K., Yonezawa, T., Matsuki, N., 2018. Comprehensive gene expression analysis of canine invasive urothelial bladder carcinoma by RNA-Seq. BMC Cancer. 18(1), 472.
Maehara, N., Arai, S., Mori, M., Iwamura, Y., Kurokawa, J., Kai, T., Kusunoki, S., Taniguchi, K., Ikeda, K., Ohara, O., Yamamura, K. I., Miyazaki, T., 2014. Circulating AIM prevents hepatocellular carcinoma through complement activation. Cell Rep. 9(1), 61-74.
Malumbres, M., 2014. Cyclin-dependent kinases. Genome Biol. 15(6), 122.
Marlowe, K. W., Robat, C. S., Clarke, D. M., Taylor, A., Touret, M., Husbands, B. D., Vail, D. M., 2018. Primary pulmonary histiocytic sarcoma in dogs: A retrospective analysis of 37 cases (2000-2015). Vet Comp Oncol. 16(4), 658-663.
Miyazaki, T., Hirokami, Y., Matsuhashi, N., Takatsuka, H., Naito, M. 1999. Increased susceptibility of thymocytes to apoptosis in mice lacking AIM, a novel murine macrophage-derived soluble factor belonging to the scavenger receptor cysteine-rich domain superfamily. J Exp Med. 189, 413-422.
Mooney, M., Bond, J., Monks, N., Eugster, E., Cherba, D., Berlinski, P., Kamerling, S., Marotti, K., Simpson, H., Rusk, T., Tembe, W., Legendre, C., Benson, H., Liang, W., Webb, C. P., 2013. Comparative RNA-Seq and microarray analysis of gene expression changes in B-cell lymphomas of Canis familiaris. PLoS One. 8(4), e61088.
Moore, A. S., Frimberger, A. E., Sullivan, N., Moore, P. F., 2012. Histologic and immunohistochemical review of splenic fibrohistiocytic nodules in dogs. J Vet Intern Med. 26(5), 1164-1168.
Moore, P. F., 1984. Systemic Histiocytosis of Bernese mountain dogs. Vet Pathol. 21, 554-563.
Moore, P. F., 2014. A Review of Histiocytic Diseases of Dogs and Cats. Vet Pathol. 51(1), 167-184.
Moore, P. F., Affolter, V. K., Vernau, W., 2006. Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11dþ macro- phages. Vet Pathol. 43(5), 632-645.
Moore, P. F., Rosin, A., 1986. Malignant histiocytosis of bernese mountain dogs. Vet Pathol. 23, 1-10.
Mulligan, R. M.,1948. Neoplastic diseases of dogs, II: mast cell sarcoma, lymphosarcoma, histiocytoma. Arch Path. 54, 147-166.
Murray, P. J., Wynn, T. A., 2011. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 11, 723-737.
Nagy, A., Lánczky, A., Menyhárt, O., Győrffy, B., 2018. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 8(1), 9227.
Nakazawa, K., Dashzeveg, N., Yoshida, K., 2014. Tumor suppressor p53 induces miR-1915 processing to inhibit Bcl-2 in the apoptotic response to DNA damage. FEBS J. 281(13), 2937-2944.
Nikolova, T., Roos, W. P., Krämer, O. H., Strik, H. M., Kaina, B., 2017. Chloroethylating nitrosoureas in cancer therapy: DNA damage, repair and cell death signaling. Biochim Biophys Acta Rev Cancer. 1868(1), 29-39.
Padgett, G. A., Madewell, B. R., Keller, E. T., Jodar, L., Packard, M., 1995. Inheritance of histiocytosis in Bernese mountain dogs. J Small Anim Pract. 36(3), 93-98.
Parker, H. G., Dreger, D. L., Rimbault, M., Davis, B. W., Mullen, A. B., Carpintero-Ramirez, G., Ostrander, E. A., 2017. Genomic Analyses Reveal the Influence of Geographic Origin, Migration, and Hybridization on Modern Dog Breed Development. Cell Rep. 19(4), 697-708.
Pinto, J. A., Rolfo, C., Raez, L. E., Prado, A., Araujo, J. M., Bravo, L., Fajardo, W., Morante, Z. D., Aguilar, A., Neciosup, S. P., Mas, L. A., Bretel, D., Balko, J. M., Gomez, H. L., 2017. In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies. Sci Rep. 7(1), 1526.
Poirier, V. J., Burgess, K. E., Adams, W. M., Vail, D. M., 2004. Toxicity, dosage, and efficacy of vinorelbine (Navelbine) in dogs with spontaneous neoplasia. J Vet Intern Med.18(4), 536-539.
Qu, P., Du, H., Li, Y., Yan, C., 2009. Myeloid-specific expression of Api6/ AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung. J Immunol. 182, 1648-1659.
Rassnick, K. M., Moore, A. S., Russell, D. S., Northrup, N. C., Kristal, O., Bailey, D. B., Flory, A. B., Kiselow, M. A., Intile, J. L., 2010. Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma. J Vet Intern Med. 24, 1528-1531.
Rodríguez-Fernández, J. L., 2013. Antigen presentation by dendritic cells in rheumatoid arthritis. Curr Top Med Chem. 13(6), 712-719.
Rowell, J. L., McCarthy, D. O., Alvarez, C. E., 2011. Dog models of naturally occuring cancer. Trends Mol Med. 17(7), 380-388.
Ruple, A., Morley, P. S., 2016. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs. J Vet Intern Med. 30, 1197-1203.
Sanjurjo, L., Amézaga, N., Aran, G., Naranjo-Gómez, M., Arias, L., Armengol, C., Borràs, F. E., Sarrias, M. R., 2015a. The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses. Autophagy. 11(3), 487-502.
Sanjurjo, L., Aran, G., Roher, N., Valledor, A. F., Sarrias, M. R., 2015b. AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease. J Leukoc Biol. 98(2),173-184.
Sarrias, M. R., Rosello, S., Sanchez-Barbero, F., Sierra, J. M., Vila, J., Yelamos, J., Vives, J., Casals, C., Lozano, F., 2005. A role for human SPα as a pattern recognition receptor. J Biol Chem. 280(42), 35391-35398.
Shaiken, S. C., Evans, S. M., Goldschmidt, M. H., 1991. Radiographic findings in canine malignant histiocytosis. Vet Radiol. 32, 237-242.
Shiotsuka, M., Wada, H., Kiyoshima, T., Nagata, K., Fujiwara, H., Kihara, M., Hasegawa, K., Someya, H., Takahashi, I., Sakai, H., 2013. The expression and function of thymosin beta 10 in tooth germ development. Int J Dev Biol. 57(11-12), 873-883.
Skala, S. L., Lucas, D. R., Dewar, R., 2018. Histiocytic Sarcoma: Review, Discussion of Transformation From B-Cell Lymphoma, and Differential Diagnosis. Arch Pathol Lab Med. 142(11), 1322-1329.
Skorupski, K. A., Clifford, C. A., Paoloni, M. C., Lara-Garcia, A., Barber, L., Kent, M. S., LeBlanc, A. K., Sabhlok, A., Mauldin, E. A., Shofer, F. S., Couto, C. G., Sørenmo, K. U., 2007. CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med. 21, 121-126.
Song, C., Su, Z., Guo, J., 2019. Thymosin β 10 is overexpressed and associated with unfavorable prognosis in hepatocellular carcinoma. Biosci Rep. 39(3), pii: BSR20182355.
Song, Y., Tang, C., Yin, C., 2018. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Biomaterials. 185, 117-132.
Sugisawa, R., Komatsu, G., Hiramoto, E., Takeda, N., Yamamura, K., Arai, S., Miyazaki, T., 2018. Independent modes of disease repair by AIM protein distinguished in AIM-felinized mice. Sci Rep. 8(1), 13157.
Sultan, M., Schulz, M. H., Richard, H., Magen, A., Klingenhoff, A., Scherf, M., Seifert, M., Borodina, T., Soldatov, A., Parkhomchuk, D., Schmidt, D., O'Keeffe, S., Haas, S., Vingron, M., Lehrach, H., Yaspo, M. L., 2008. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome. Science. 321(5891), 956-960.
Swerdlow, S. H., Campo, E., Harris, N. L., 2008. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer.
Szymański, P., Olszewska, P., Mikiciuk-Olasik, E., Różalski, A., Maszewska, A., Markiewicz, Ł., Cuchra, M., Majsterek, I., 2017. Novel tetrahydroacridine and cyclopentaquinoline derivatives with fluorobenzoic acid moiety induce cell cycle arrest and apoptosis in lung cancer cells by activation of DNA damage signaling. Tumour Biol. 39(3), 1010428317695011.
Takada, M., Hix, J. M. L., Corner, S., Schall, P. Z., Kiupel, M., Yuzbasiyan-Gurkan, V., 2018.
Targeting MEK in a Translational Model of Histiocytic Sarcoma. Mol Cancer Ther. 17(11), 2439-2450.
Takada, M., Smyth, L. A., Thaiwong, T., Richter, M., Corner, S. M., Schall, P. Z., Kiupel, M., Yuzbasiyan-Gurkan, V., 2019. Activating Mutations in PTPN11 and KRAS in Canine Histiocytic Sarcomas. Genes (Basel). 10(7). pii: E505.
Takahashi, M., Tomiyasu, H., Hotta, E., Asada, H., Fukushima, K., Kanemoto, H., Fujino, Y., Ohno, K., Uchida, K., Nakayama, H., Tsujimoto, H., 2014. Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan. J Vet Med Sci. 76(5), 661-666.
Tanaka, H., Matsushima, H., Mizumoto, N., Takashima, A., 2009. Classification of chemotherapeutic agents based on their differential in vitro effects on dendritic cells. Cancer Res. 69(17), 6978-6986.
Taylor, D. O., Dorn, C. R., Luis, O. H., 1969. Morphologic and biologic characteristics of the canine cutaneous histiocytoma. Cancer Res. 29(1), 83-92.
Tomura, S., Uchida, M., Yonezawa, T., Kobayashi, M., Bonkobara, M., Arai, S., Miyazaki, T., Tamahara, S., Matsuki, N., 2014. Molecular cloning and gene expression of canine apoptosis inhibitor of macrophage. J Vet Med Sci. 76(12), 1641-1645.
Uchida, M., Saeki, K., Maeda, S., Tamahara, S., Yonezawa, T., Matsuki, N., 2016. Apoptosis inhibitor of macrophage (AIM) reduces cell number in canine histiocytic sarcoma cell lines. J Vet Med Sci. 78(9), 1515-1520.
Uchida, M., Uchida, K., Maeda, S., Yonezawa, T., 2019. Expression of apoptosis inhibitor of macrophages in tissue macrophages, leukocytes and vascular endothelial cells of dogs. Tissue Cell. 58, 112-120.
Vail, D. M., Kravis, L. D., Cooley, A. J., Chun, R., MacEwen, E. G., 1997. Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors. Cancer Chemother Pharmacol. 39(5), 410-416.
Valastyan, S., Weinberg, R. A., 2011. Tumor metastasis: molecular insights and evolving paradigms. Cell. 147(2), 275-292.
Valledor, A. F., Hsu, L. C., Ogawa, S., Sawka-Verhelle, D., Karin, M., Glass, C. K., 2004. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc. Natl. Acad. Sci. 101, 17813-17818.
van Kuijk, L., van Ginkel, K., de Vos, J. P., Brearley, M. J., Butinar, J., Gielen, I., van Garderen, E., Chiers, K., Verhoeven, P. S., 2013. Peri-articular Histiocytic Sarcoma and Previous Joint Disease in Bernese Mountain Dogs. J Vet Intern Med. 27, 293-299.
Vaser, R., Adusumalli, S., Leng, S. N., Sikic, M., Ng, P. C., 2015. SIFT missense predictions for genomes. Nat Protoc. 11(1), 1-9.
Vaupel, P., Mayer, A., Höckel, M., 2004. Tumor hypoxia and malignant progression. Methods Enzymol. 381, 335-354.
Viale, G., Giobbie-Hurder, A., Regan, M. M., Coates, A. S., Mastropasqua, M. G., Dell'Orto, P., Maiorano, E., MacGrogan, G., Braye, S. G., Ohlschlegel, C., Neven, P., Orosz, Z., Olszewski, W. P., Knox, F., Thürlimann, B., Price, K. N., Castiglione-Gertsch, M., Gelber, R. D., Gusterson, B. A., Goldhirsch, A., 2008. Breast International Group Trial 1-98., 2008. Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole. J Clin Oncol. 26(34), 5569-5575.
Vincze, O., Tökési, N., Oláh, J., Hlavanda, E., Zotter, A., Horváth, I., Lehotzky, A., Tirián, L., Medzihradszky, K. F., Kovács, J., Orosz, F., Ovádi, J., 2006. Tubulin polymerization promoting proteins (TPPPs): members of a new family with distinct structures and functions. Biochemistry. 45(46), 13818-13826.
Wang, C., Yosef, N., Gaublomme, J., Wu, C., Lee, Y., Clish, C. B., Kaminski, J., Xiao, S., Horste, M. Z. G., Pawlak, M., Kishi, Y., Joller, N., Karwacz, K., Zhu, C., Ordovas-Montanes, M., Madi, A., Wortman, I., Miyazaki, T., Sobel, R. A., Park, H., Regev, A., Kuchroo, V. K., 2015. CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity. Cell. 163(6),1413-1427.
Wang, H. F., Zheng, S. F., Chen, Y., Zhou, Z. Y., Xu, J., 2018. Correlations between claudin-1 and PIGF expressions in retinoblastoma. Eur Rev Med Pharmacol Sci. 22(13), 4196-4203.
Wang, L., Wang, Y., Zhang, C., Li, J., Meng, Y., Dou, M., Noguchi, C. T., Di, L., 2018. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration. Arterioscler Thromb Vasc Biol. 38(9), 2103-2116.
Wellman M. L., Krakowka S., Jacobs R. M., Kociba G. J., 1988. A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell Dev Biol. 24, 223-229.
Wu, T., Dai, Y., 2016. Tumor microenvironment and therapeutic response. Cancer Lett. 387, 61-68.
Yan, Y., Xu, Z., Hu, X., Qian, L., Li, Z., Zhou, Y., Dai, S., Zeng, S., Gong, Z., 2018. SNCA Is a Functionally Low-Expressed Gene in Lung Adenocarcinoma. Genes (Basel). 9(1), pii: E16.
Ye, K., Li, Y., Zhao, W., Wu, N., Liu, N., Li, R., Chen, L., He, M., Lu, B., Wang, X., Hu, R., 2017. Knockdown of Tubulin Polymerization Promoting Protein Family Member 3 inhibits cell proliferation and invasion in human colorectal cancer. J Cancer. 8(10), 1750-1758.
Yu, F. X., Lin, S. C., Morrison-Bogorad, M., Yin, H. L., 1994. Effects of thymosin beta 4 and thymosin beta 10 on actin structures in living cells. Cell Motil Cytoskeleton. 27, 13-25.
Yusa, S., Ohnishi, S., Onodera, T., Miyazaki, T., 1999. AIM, a murine apoptosis inhibitory factor, induces strong and sustained growth inhibition of B lymphocytes in combination with TGF-beta1. Eur. J. Immunol. 29, 1086-1093.
Zhang, X. J., Su, Y. R., Liu, D., Xu, D. B., Zeng, M. S., Chen, W. K., 2014. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma. J Surg Res. 192(2), 487-493.
Zhang, X., Ren, D., Guo, L., Wang, L., Wu, S., Lin, C., Ye, L., Zhu, J., Li, J., Song, L., Lin, H., He,
Z., 2017. Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer. Breast Cancer Res. 19(1), 15.
Zhu, Y., Zhai, K., Ke, J., Li, J., Gong, Y., Yang, Y., Tian, J., Zhang, Y., Zou, D., Peng, X., Gong, J., Zhong, R., Huang, K., Chang, J., Miao, X., 2017. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population. Oncotarget. 8(22), 36033-36039.